This inventor holds 1 USPTO granted patent and 1 published patent application. Top assignee: Sun Bio, Inc.. Active years: 2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 2025
Title: Minjung Ahn: Innovator in Hemoglobin Derivatives
Introduction
Minjung Ahn is a prominent inventor based in Gyeonggi-do, South Korea. She has made significant contributions to the field of biomedical innovations, particularly in the development of blood substitutes. Her work focuses on enhancing the safety and efficacy of hemoglobin derivatives.
Latest Patents
Minjung Ahn holds a patent for a "Hemoglobin derivative co-conjugated with fatty acid-linked PEG and alkoxy PEG as a blood substitute." This invention relates to a hemoglobin derivative that is co-conjugated with both fatty acid-linked polyethylene glycol (FA-PEG) derivatives and alkoxy polyethylene glycol (alkoxy-PEG) derivatives. The patent outlines a method for creating such hemoglobin derivatives, which include crosslinked hemoglobin exhibiting non-toxicity and extended intravascular retention time. She has 1 patent to her name.
Career Highlights
Minjung Ahn is currently associated with Sun Bio, Inc., where she continues to advance her research in blood substitutes. Her innovative approach has positioned her as a key figure in her field, contributing to the development of safer medical solutions.
Collaborations
Minjung has collaborated with notable colleagues, including Kwang Nho and Changmin Hyun, to further her research and development efforts.
Conclusion
Minjung Ahn's work in hemoglobin derivatives represents a significant advancement in medical technology. Her innovative contributions are paving the way for safer blood substitutes, showcasing her dedication to improving healthcare solutions.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile